This page lists the SEC filings reported by DAFNA Capital Management LLC.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | DAFNA Capital Management LLC | ENCISION INC | 964,662 | 8.2% | EDGAR |
| SC 13G | 2024-02-14 | DAFNA Capital Management LLC | Regulus Therapeutics Inc. | 1,111,049 | 5.5% | EDGAR |
| SC 13G/A | 2023-02-14 | DAFNA Capital Management LLC | ENCISION INC | 964,662 | 8.2% | EDGAR |
| SC 13G/A | 2022-02-14 | DAFNA Capital Management LLC | ENCISION INC | 964,662 | 8.2% | EDGAR |
| SC 13G/A | 2021-02-16 | DAFNA Capital Management LLC | ENCISION INC | 985,000 | 8.5% | EDGAR |
| SC 13G/A | 2020-02-14 | DAFNA Capital Management LLC | ENCISION INC | 985,000 | 8.5% | EDGAR |
| SC 13G/A | 2019-02-14 | DAFNA Capital Management LLC | ENCISION INC | 985,000 | 8.5% | EDGAR |
| SC 13D/A | 2018-03-08 | DAFNA Capital Management LLC | Stereotaxis, Inc. | 13,680,554 | 23.4% | EDGAR |
| SC 13G/A | 2018-02-14 | DAFNA Capital Management LLC | ENCISION INC | 1,047,500 | 9.8% | EDGAR |
| SC 13G/A | 2018-02-14 | DAFNA Capital Management LLC | SUNESIS PHARMACEUTICALS INC | 983,000 | 2.9% | EDGAR |
| SC 13D/A | 2017-02-14 | DAFNA Capital Management LLC | Stereotaxis, Inc. | 1,372,862 | 6.3% | EDGAR |
| SC 13G | 2017-02-14 | DAFNA Capital Management LLC | ENCISION INC | 1,047,500 | 9.8% | EDGAR |
| SC 13G | 2017-02-14 | DAFNA Capital Management LLC | SUNESIS PHARMACEUTICALS INC | 1,133,583 | 5.4% | EDGAR |
| SC 13G | 2017-02-14 | DAFNA Capital Management LLC | WINDTREE THERAPEUTICS INC /DE/ | 208,333 | 2.4% | EDGAR |
| SC 13D/A | 2017-02-06 | DAFNA Capital Management LLC | Stereotaxis, Inc. | 2,280,212 | 10.0% | EDGAR |
| SC 13D/A | 2017-01-09 | DAFNA Capital Management LLC | Stereotaxis, Inc. | 2,280,212 | 10.0% | EDGAR |
| SC 13D | 2016-10-11 | DAFNA Capital Management LLC | Stereotaxis, Inc. | 1,372,862 | 6.3% | EDGAR |
| SC 13G | 2016-02-16 | DAFNA Capital Management LLC | ANAVEX LIFE SCIENCES CORP. | 0 | 0.0% | EDGAR |
| SC 13G | 2016-02-16 | DAFNA Capital Management LLC | ENCISION INC | 1,047,500 | 9.8% | EDGAR |
| SC 13G | 2016-02-16 | DAFNA Capital Management LLC | Stereotaxis, Inc. | 1,372,862 | 6.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.